Remimazolam and Remifentanil Use Induced Severe Respiratory Depression and Laryngeal Spasm During Intravenous Sedation and Analgesia: A Case Report

CONCLUSION: We aim to improve awareness about the safety of these drugs among anesthesiologists and increase their ability to manage the risk associated with their use.PMID:37198992 | DOI:10.2174/1574886318666230517101142
Source: Current Drug Safety - Category: Drugs & Pharmacology Authors: Source Type: research